The Cochrane Collaboration
Cochrane Reviews
Explore New + Updated Other languages
Full Text:  The Cochrane Library
search & browse | by topic | full list of all reviews | by country of author | by date range

by Topic (Review Group):
Visit the "Haematological Malignancies Group" website here

Browse by topic (Review Group) - For sub-topics (only reviews + protocols), click here

Suggest a topic


View stages (what is this?): all titles Titles protocol Protocols review Reviews

All -trans -retinoic -acid for acute myelogenous leukemia (title stage)
Allogeneic hematopoietic cell transplantation for acute lymphoblastic leukemia (ALL) in first complete remission (title stage)
Allogeneic peripheral blood stem cell transplantation versus conventional therapy for advanced primary cutaneous T-Cell lymphoma (title stage)
Alternative thresholds for initiating treatment of Epoetin or Darbepoetin in cancer patients (title stage)
Arsenic trioxide for the treatment of acute promyelocytic leukaemia (title stage)
Bendamustine for patients with indolent lymphoma (title stage)
Clinical use of haematopoietic growth factors in the treatment for myelodysplastic syndrome (title stage)
Comparison of anthracyclines in induction chemotherapy for AML (title stage)
Darbepoetin versus rHuErythropoetin for patients with malignant diseases (title stage)
Dexamethasone monotherapy versus chemotherapy or chemotherapy plus dexamethasone for multiple myeloma (title stage)
Fludarabine and high-dose Ara-C based regimens in induction chemotherapy for AML (title stage)
Granulopoiesis-stimulating factors in autologous peripheral stem cell transplantation for haematological malignancy (title stage)
High-dose chemotherapy followed by autologous stem cell transplantation for the therapy of first relapse of Hodgkin lymphoma (title stage)
Imatinib for adult patients with philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ALL) (title stage)
Imatinib for treating patients with Chronic Myelogeneous Leukemia (title stage)
Imatinib for treating patients with chronic myelogeneous leukemia (title stage)
Intravenous immunoglobulins for the treatment of infections in patients with haematological cancers (title stage)
Mono-therapy of Hypomethylating Agents for the Treatment of Patients with Acute Myeloid Leukemia or advanced Myeolodysplastic Syndrome (title stage)
Multi-drug resistance (MDR) modifiers for the treatment of acute myeloid leukaemia (title stage)
Nonmyeloablative allogeneic stem cell transplantation versus standard stem cell Transplantation for haematological malignancies (title stage)
Optimisation of chemotherapy and radiotherapy for untreated Hodgkin lymphoma patients with respect to second malignant neoplasms, overall and progression-free survival (title stage)
Optimisation of chemotherapy and radiotherapy for untreated Hodgkin lymphoma with respect to second malignant neoplasms, overall and progression-free survival (title stage)
Pegfilgrastim for patients with malignant disease undergoing myelosuppressive chemotherapy (title stage)
Pegylated liposomal doxorubicin for relapsed or refractory multiple myeloma (title stage)
Physical Exercise for Patients with Hematological Malignancies (title stage)
Prevention and treatment for mucositis in bone marrow grafted patients (title stage)
Priming using colony stimulating factors for induction therapy in acute myeloid leukaemia (title stage)
Radioimmunotherapy for lymphoma (title stage)
Recombinant human keratinocyte growth factors for the treatment of malignant disease (title stage)
Rituximab for aggressive Non-Hodgkin Lymphoma (title stage)
Role of thalidomide, and its analogues, as therapy for multiple myeloma (title stage)
Role of Velcade as therapy for multiple myeloma (title stage)
The effect of Erythropoiesis-stimulating Agents for cancer patients regardings Quality of Life: Individual Patient Data Meta-Analysis based on Randomized Controlled Trials (title stage)
The role of allogeneic stem cell transplantation for peripheral T-cell lymphomas (title stage)
The role of colony stimulating factors administered for prevention and treatment of infectious complications in patients with acute myelogenous leukemia (title stage)
The role of dose intensification with or without autologous stem cell transplantation for peripheral T-cell lymphomas (title stage)
TPO receptor agonist for chronic idiopathic thrombocytopenic purpura (title stage)
Treatment for disseminated intravascular coagulation in patients with acute and chronic leukemia (title stage)
Vaccination for Non-Hodgkin Lymphoma (title stage)